Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2006
10/19/2006US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2)
10/19/2006US20060234239 An oligonucleotide targeted to (hybridizing with) a nucleic acid molecule encoding human insulin like growth factor I receptor; treatment of proliferative and inflammatory skin disorders and cancer
10/19/2006US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006US20060233804 IGF antagonist peptides
10/19/2006US20060233796 Method of modulating memory effector T-cells and compositions
10/19/2006US20060233783 Topical composition in the form of a gel for treating skin burns
10/19/2006US20060233738 Composition for promoting production of type 1 collagen and/or elastin
10/19/2006US20060233737 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same
10/19/2006US20060233735 Psoriasis; applying daily to hair an aqueous mixture of clobetasol propionate, an anionic surfactant, an amphoteric surfactant, and ethanol; leaving it for 2.5 to 15 minutes, and rinsing with water.
10/19/2006US20060233729 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners
10/19/2006US20060233727 Film foaming hydroalcoholic foam
10/19/2006US20060233714 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions
10/19/2006DE102005021382A1 Agent, useful to treat and prevent skin diseases e.g. psoriasis, preferably psoriasis of the palms and foot, nail psoriasis, neurodermatitis and atopic dermatitis, comprises zeolite, stinging nettle extract and further materials
10/19/2006CA2604028A1 Novel use of zinc gluconate for treating hydradenitis suppurativa
10/19/2006CA2603457A1 Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof
10/19/2006CA2602968A1 Crystals of morphinan derivative and process for producing the same
10/18/2006EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006EP1712236A2 Methods of treating acne
10/18/2006EP1711210A2 Combined use of prame inhibitors and hdac inhibitors
10/18/2006EP1711194A1 A plant extract and its pharmaceutical and cosmetic use
10/18/2006EP1711190A1 Agent for treating inflammatory diseases
10/18/2006EP1711177A1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS
10/18/2006EP1572683B1 Novel piperidine derivatives as modulators of chemokine receptor ccr5
10/18/2006EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006EP1283828B1 Novel polymorph v of torasemide
10/18/2006EP1239850B1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents
10/18/2006EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/18/2006EP1107957B1 Pyrimidine compounds
10/18/2006CN1849400A Polynucleotides and polypeptides of the erythropoietin gene
10/18/2006CN1849135A Methods for treating interleukin-6-related diseases
10/18/2006CN1849125A Therapeutic agent for ageing macular degeneration
10/18/2006CN1847263A Protein from snake venom for preventing and treating pyemia
10/18/2006CN1847262A One kind of protein and its use
10/18/2006CN1847261A Cyclic peptides as g-protein-coupled receptor antagonists
10/18/2006CN1847229A Novel compounds
10/18/2006CN1846774A Specific Chinese medicine health tea with functions of beautifying and moistening skin
10/18/2006CN1846771A Spot-eliminating and physique strengthening composition
10/18/2006CN1846769A Production process and usage of skin care Chinese medicine capsule
10/18/2006CN1846754A Externally applied Chinese herbal medicine prepn for treating burns and scalds
10/18/2006CN1846745A Prepn process of psoriasis treating ointment
10/18/2006CN1846738A Medicine composition and its prepn process and quality control method
10/18/2006CN1846733A Externally applied skin care liquid extracted from plant and its prepn process
10/18/2006CN1846718A Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
10/18/2006CN1846713A Snake venom extract for preventing and treating pyemia
10/18/2006CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/18/2006CN1279975C Inducer of blood vessel neogenesis
10/18/2006CN1279968C Chinese medicine for treating white hair and its preparing method
10/18/2006CN1279966C Danduqing granular and its preparation method
10/18/2006CN1279952C Medicine for treating burns and scalds
10/18/2006CN1279946C Medicinal wine and its producing method
10/18/2006CN1279940C Antiseptic and pest killing skin cleaning agent and preparing method
10/18/2006CN1279937C Antiseptic and insect killing washing liquid and preparing method
10/18/2006CN1279926C Medicine for treating burns and scalds and its preparation method
10/18/2006CN1279917C Vulnerary, its preparation method and process of using
10/18/2006CN1279914C Minoxidil-containing preparations
10/18/2006CN1279902C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/18/2006CN1279901C Pharmaceutical composition for the treatment of seborrhea containing 4-hydroxy-5-methoxy-4-[2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro[2,5]octan-6-one
10/18/2006CN1279894C Preparations for coating wound
10/17/2006US7122679 Multicyclic compounds and the use thereof
10/17/2006US7122677 NK1 antagonists
10/17/2006US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006US7122665 Heterocyclic compounds
10/17/2006US7122639 Chemokine alpha-2 antibodies
10/17/2006US7122635 Method and composition for angiogenesis inhibition
10/17/2006US7122556 Phenylalanine enamide derivatives
10/17/2006US7122551 Metalloproteinase inhibitor compounds
10/17/2006US7122550 Protein kinase inhibitors
10/17/2006US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006US7122544 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
10/17/2006US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases
10/17/2006US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006US7122524 Stimulating nerve growth, administering glycyl-L-phenylalanyl-L-prolineamide, N,N-diethyl-isoleucyl-phenylalanyl-L-proline ethylamide, N,N-diethyl-isoleucyl-isoleucyl-prolineamide; due to ischemic, traumatic or toxic origin
10/17/2006US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/17/2006US7122187 Treating autoimmune diseases with humanized anti-CD40L antibody
10/17/2006US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006CA2352964C A method for enhancing protective cellular responses to genotoxic stress in skin
10/17/2006CA2322502C Protease inhibitors in absorbent articles
10/17/2006CA2212888C A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
10/17/2006CA2177179C Antagonists to chaperonin 10
10/17/2006CA2148988C Filamentous bacteria extracts used as cosmetic agents against the ageing of skin
10/12/2006WO2006107184A1 A pharmaceutical composition for the treatment of atopic dermatitis containing 4-hydroxy-5-methoxy-4-[2-methyl-3-(3-methyl-2-butenyl)-2-oxiranyl]-1-oxaspiro [2,5]octan-6-one
10/12/2006WO2006106914A1 Novel cyclic compound having pyrimidinylalkylthio group
10/12/2006WO2006106727A1 Benzyloxypropylamine derivative
10/12/2006WO2006106633A1 Uv-induced dermatitis inhibitor and atopic dermatitis inhibitor
10/12/2006WO2006106528A1 Novel peptides useful for treatment of alopecia
10/12/2006WO2006106398A1 Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
10/12/2006WO2006106220A2 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals.
10/12/2006WO2006106164A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles
10/12/2006WO2006105811A1 Compounds useful as modulators of the proteasome activity
10/12/2006WO2006105665A1 Hydrogel composition for modulation of topical inflammatory response
10/12/2006WO2006063865A3 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing osmrbeta as a subunit, and applications thereof
10/12/2006WO2006047516A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/12/2006WO2006040688A3 Inhibitors of acetylcholinesterase for treating skin diseases
10/12/2006US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
10/12/2006US20060229346 Method for treating vascular hyperpermeable disease
10/12/2006US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006US20060229316 Novel antiinfective compounds, process for their preparation and pharmaceutical compositions containing them